Skip to main content

What the FDA labels say about taking them together

Digoxin and epinephrine

Digoxin's FDA label of December 5, 2024 names epinephrine in its drug interactions section; the epinephrine labels PlainMeds reads (4) do not name digoxin. The digoxin label: “Sympathomimetics Epinephrine Can increase the risk of cardiac arrhythmias.”

Check it at the source: the digoxin FDA label on DailyMed (effective December 5, 2024, Advanz Pharma (US) Corp.); the epinephrine FDA label on DailyMed (effective July 13, 2026, A-S Medication Solutions).

What does the digoxin label say about epinephrine?

Digoxin label, drug interactions

Sympathomimetics; Epinephrine Norepinephrine Dopamine; Can increase the risk of cardiac arrhythmias

Source: FDA drug label (Digoxin, NDA021648), Hikma Pharmaceuticals USA Inc., effective April 10, 2025 (SPL set 1b7e5c6e-e052-41b0-a4ce-05dfe62faaaf), via openFDA

Source: FDA drug label (LANOXIN), Advanz Pharma (US) Corp., effective December 5, 2024 (SPL set d91e3646-4c63-4512-ab22-db39c085c4dc), via openFDA; the full label on DailyMed

What does the epinephrine label say about digoxin?

Epinephrine's label (effective July 13, 2026) and its 3 other brand-application labels do not name digoxin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Epinephrine), A-S Medication Solutions, effective July 13, 2026 (SPL set 6e811e28-0199-4df7-a916-5940c632401d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

26Digoxin generic labelers
16Epinephrine generic labelers
DigoxinEpinephrine
Labeled forHeart failure, Atrial fibrillationAsthma
Boxed warningNoNo
Pharmacy cost (NADAC)$0.133 per tablet 125 mcg tablet$123.51 per unit 0.15 mg auto-injct
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?